Downregulation of TLR4, MyD88, and AP1 subunits was observed in the RA group relative to the NASH group, which indicates that a crucial mechanism through which RA might suppress inflammation is by altering the mRNA expression of genes in the TLR4/AP1 signaling pathway in hepatocytes. The gene discussed is FOS; the disease is metabolic dysfunction-associated steatohepatitis.